Previous 10 | Next 10 |
Zynex, Inc. (ZYXI) Q2 2022 Results Conference Call July 28, 2022 04:15 PM ET Company Participants Louisa Smith - Investor Relations-Gilmartin Group Thomas Sandgaard - Chairman, President and Chief Executive Officer Dan Moorhead - Chief Financial Officer Anna ...
Zynex press release ( NASDAQ: ZYXI ): Q2 GAAP EPS of $0.08 beats by $0.01 . Revenue of $36.76M (+18.6% Y/Y) beats by $0.46M . Zynex is reaffirming its full year 2022 revenue estimates in the range of $150-$170 million and Adjusted EBITDA between $25-$35 million...
Zynex Announces 2022 Second Quarter Earnings PR Newswire ENGLEWOOD, Colo. , July 28, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa...
Zynex ( NASDAQ: ZYXI ) is scheduled to announce Q2 earnings results on Thursday, July 28th, after market close. The consensus EPS Estimate is $0.07 and the consensus Revenue Estimate is $36.3M (+17.1% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward rev...
AAPL , AEMD , AJG , ALEX , AMZN , APPF , ATR , AUY , AVTR , AXTI , BIO , OTCPK:BTEGF , BZH , CC , CE , CLFD , CLR , COHU , CPT , CTO , CUZ , CWST , DECK , DLR , DXCM , EB , EBC , ...
Zynex continues to grow its top-line sequentially, set to post another record quarter in Q2. Despite this, investors have punished the stock in FY22, in search of idiosyncratic risk premia over beta-related return. In that vein, we find a lack of equity premia in ZYXI that investo...
Zynex, Inc. to Announce Second Quarter 2022 Financial Results PR Newswire ENGLEWOOD, Colo. , July 20, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medic...
Zynex ( NASDAQ: ZYXI ) reports that Q2 orders grew 19% Q/Q and 10% Y/Y, over Q2 2021, hitting the highest order total in Company history. Cash collections also remained strong during Q2. The company re-affirms Q2 revenue guidance of $35M-$38M ( $36.55M consensus ), up ...
Zynex Reports Preliminary Second Quarter 2022 Results and Reiterates Full Year Revenue and EBITDA Guidance PR Newswire ENGLEWOOD, Colo. , July 11, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in t...
Gainers: Ocean Bio-Chem OBCI +117%. Exela Technologies XELA +47%. Boxed BOXD +44%. Revlon REV +39%. Vivakor (VIVK) +22%. Omeros Corporation (OMER) +21%. Vor Biopharma (VOR) +21%. Wave Life Sciences WVE +18%. Siyata Mobile (SYTA) +18%. Visionary Education Technology (V...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...